Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells.

Int J Mol Sci · 2024 · PMC10932193 · PMID 38474121

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

Taken together, the implications of these results are quite significant and the clinical application of PRKAR1A is quite limited because this protein functions oppositely in cancer cells and CSCs.

also in 5,705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.